Ratings Wipro Limited NSE India S.E.

Equities

WIPRO

INE075A01022

Market Closed - NSE India S.E. Other stock markets 07:43:50 2024-05-03 am EDT			5-day change	1st Jan Change
457.4 ^INR	-0.01%		-1.56%	-2.96%

May. 02	Asian Equities Traded in the US as American Depositary Receipts Rise Sharply in Thursday Trading	MT
May. 02	Wipro Limited to Implement Independent Health's Medicare Prescription Payment Plan Platform	CI

Strengths

Thanks to a sound financial situation, the firm has significant leeway for investment.
Considering the small differences between the analysts' various estimates, the group's business visibility is good.

Weaknesses

As estimated by analysts, this group is among those businesses with the lowest growth prospects.
The company's earnings growth outlook lacks momentum and is a weakness.
In relation to the value of its tangible assets, the company's valuation appears relatively high.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: IT Services & Consulting

	1st Jan change	Capi.	ESG Refinitiv
WIPRO LIMITED	-2.96%	28.6B	-
ACCENTURE PLC	-13.45%	191B	A-
TATA CONSULTANCY SERVICES LTD.	+1.32%	167B	B+
IBM	+1.32%	152B	B-
AUTOMATIC DATA PROCESSING, INC.	+3.83%	99B	A-
RELX PLC	+7.97%	78.79B	A-
CROWDSTRIKE HOLDINGS, INC.	+21.50%	75.03B	C-
INFOSYS LIMITED	-8.21%	70.51B	A
SNOWFLAKE INC.	-19.94%	53.21B	C
HCL TECHNOLOGIES LIMITED	-8.05%	43.78B	A-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes